Adicet Bio, Inc.

About Adicet Bio, Inc.

Adicet Bio is focused on delivering best-in-class gamma delta T cell therapies for patients fighting autoimmune diseases and cancer, leveraging a novel platform to develop innovative immune cell therapies.

Products & Services

Allogeneic Gamma Delta 1 CAR T Cell Therapy:A new generation of immune cell therapy featuring novel targeting, tissue homing, best-in-class drug exposure, and on-demand availability.

ADI-001:A therapy under Phase 1 study for patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE).

Specialties

Gamma Delta T Cell Therapies Immune Cell Therapy Autoimmune Diseases Cancer Treatment Allogeneic CAR T Cell Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 80000000 MR: - FA: $80.0 million FAN: 80000000	D: 2025-10-07 FD: 2025-10-07	5 investors
2	RT: Public Follow-On Offering T: - FT: Public Follow-On Offering	A: 98000000 MR: - FA: $98 million FAN: 98000000	D: 2024-01-25 FD: 2024-01-25	5 investors
3	RT: Public Offering T: - FT: Public Offering	A: 85200000 MR: - FA: approximately $85.2 million FAN: 85200000	D: 2024-01-23 FD: 2024-01-23	5 investors

Registered Direct Offering Latest

2025-10-07

$80.0M

5 investors (Pro only)

Public Follow-On Offering 2024-01-25

$98.0M

Public Offering 2024-01-23

$85.2M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chen Schor

President and Chief Executive Officer

B

Blake Aftab

Chief Scientific Officer

J

Julie Maltzman

Chief Medical Officer

N

Nick Harvey

Chief Financial Officer

D

Don Healey

Chief Technology Officer

A

Amy Locke

Chief Human Resources Officer

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Adicet Bio, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised